ANCHOR presentation at ASH 2020
December 6, 2020
Oncopeptides presented new data from phase 2 ANCHOR combination study in multiple myeloma the 62nd American Society of Hematology virtual annual meeting ASH, December 6, 2020.
See presentation below.
Menu
-
Change Region
-
Global
-
Germany
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our German operations at oncopeptides.de
-
Spain
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our Spanish operations at oncopeptides.es
-
United States
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our US operations at oncopeptides-us.com
Change Language
-
-
ONCO2.12 SEK+0.5%0.01 SEK
-
-
Change Region
-
Global
-
Germany
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our German operations at oncopeptides.de
-
Spain
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our Spanish operations at oncopeptides.es
-
United States
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our US operations at oncopeptides-us.com
Change Language
-
-
ONCO2.12 SEK+0.5%0.01 SEK
-